Delivery Order SPE2DB22D1106-SPE2DB24FEUF0
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563894398 HERCEPTIN 150 MG VIALS. The contract has a potential value of $10,602.36 and a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the sole prime contractor on this delivery order, which is not associated with any set-aside designation. Additionally, Amerisourcebergen Drug Corp holds an...
- This is a $17,802.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for HERCEPTIN 150 MG VIALS and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HERCEPTIN 150 MG VIALS, a prescription medication, with a ceiling value of $21,363.36 and a completion date of July 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a firm fixed-price delivery order (SPE2DB22D1106|SPE2DB24FEEW5) awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of 4,563,970,501 units of the drug Herceptin (150 mg vials) at a ceiling value of $21,204.72. The delivery order falls under a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,681.68 firm fixed-price contract is for the delivery of 4,567,615,883 units of Herceptin 150 mg vials. The contract has an ultimate completion date of April 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Herceptin 150 mg vials. The contract has a firm fixed price of $21,937.68 and an ultimate completion date of January 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Herceptin 150 mg vials. The contract has a ceiling value of $21,204.72 and a performance period through April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is issued under a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of HERCEPTIN 150 MG VIALS. The contract is a Delivery Order with a Firm Fixed Price of $2,670.42 and a performance period extending until July 30, 2025. It was awarded on July 9, 2025 by the Defense Logistics Agency (DLA), which serves as the Defense or Civilian agency for this contract. The contract is not set aside and is open to full and...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4,563,738,045 units of HERCEPTIN 150 mg vials, a specialty pharmaceutical product, with a completion date of March 14, 2024 and a potential value of $13,252.95. The contract does not have...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,681.68, is for the delivery of HERCEPTIN 150 MG VIALS. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEUF0Delivery Order
This $21,204.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) on May 29, 2024. The contract is for the supply of 4,564,741,632 units of HERCEPTIN 150 MG VIALS, a critical pharmaceutical product, with a period of performance through June 20, 2024. This delivery order is placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies in support of the Department of Defense's military treatment programs and facilities worldwide. The contract does not have a set-aside designation, reflecting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 5/29/24 |